Cassava Sciences Net Foreign Currency Exchange Gain/Loss (Quarterly) Analysis

Cassava Sciences, Inc. (SAVA)

2.83 +0.03 (+1.07%) USD | NASDAQ | Dec 16, 11:56

View Net Foreign Currency Exchange Gain/Loss (Quarterly) for SAVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	--
Geron Corp.	--
Ovid Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	Upgrade